THE COMBINATION OF PEMBROLIZUMAB AND BEVACIZUMAB IN THE TREATMENT OF CHOLANGIOCARCINOMA BRAIN METASTASES: CASE REPORT

被引：0
|
作者：
Hua, Yunqi [1 ]
Shi, Xueshen [1 ]
Ba, Caixia [1 ]
Liu, Xianfeng [1 ]
Yang, Yongyan [1 ]
机构：
[1] Baotou Canc Hosp, Dept Oncol, Baotou, Inner Mongolia, Peoples R China
来源：
GUT | 2018年 / 67卷
关键词：
D O I：
10.1136/gutjnl-2018-IDDFabstracts.62
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
IDDF2018-A
引用
收藏
页码：A28 / A29
页数：2
相关论文
共 50 条
  • [21] Bevacizumab as Front-line Treatment of Brain Metastases from Solid Tumors: A Case Series
    Zustovich, Fable
    Ferro, Alessandra
    Lombardi, Giuseppe
    Zagonel, Vittorina
    Fiduccia, Pasquale
    Farina, Patrizia
    ANTICANCER RESEARCH, 2013, 33 (09) : 4061 - 4065
  • [22] Bevacizumab in the treatment of a patient with metastatic colorectal carcinoma with brain metastases
    Bhaskara, Achala
    Eng, Cathy
    CLINICAL COLORECTAL CANCER, 2008, 7 (01) : 65 - 68
  • [23] Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma
    Satake, Tomoyuki
    Shibuki, Taro
    Watanabe, Kazuo
    Sasaki, Mitsuhito
    Imaoka, Hiroshi
    Mitsunaga, Shuichi
    Kojima, Motohiro
    Ikeda, Masafumi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Gemcitabine in combination with EGF-receptor antibody (cetuximab) as a treatment of cholangiocarcinoma: a case report
    Sprinzl, Martin F.
    Schimanski, Carl C.
    Moehler, Markus
    Schadmand-Fischer, Simin
    Galle, Peter R.
    Kanzler, Stephan
    BMC CANCER, 2006, 6 (1)
  • [25] Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report
    Martin F Sprinzl
    Carl C Schimanski
    Markus Moehler
    Simin Schadmand-Fischer
    Peter R Galle
    Stephan Kanzler
    BMC Cancer, 6
  • [26] Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report
    Zhuang, Hongqing
    Yuan, Xiangkun
    Sun, Dayong
    Bian, Jianliang
    Chang, Joe Y.
    Yuan, Zhiyong
    Wang, Ping
    ONCOTARGET, 2016, 7 (11) : 13265 - 13268
  • [27] Mucinous cholangiocarcinoma with metastases in a Turkish Van cat - A case report
    Ilhan, Fatma
    Yener, Zabit
    Vural, Sevil Atalay
    Haligur, Mehmet
    BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY, 2008, 52 (01) : 131 - 134
  • [28] Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report
    Vitiello, F.
    Ricci, V.
    Martinelli, E.
    Orditura, M.
    DeVita, F.
    Galizia, G.
    Ciardiello, F.
    TARGETED ONCOLOGY, 2008, 3 (04) : 253 - 258
  • [29] Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report
    F. Vitiello
    V. Ricci
    E. Martinelli
    M. Orditura
    F. DeVita
    G. Galizia
    F. Ciardiello
    Targeted Oncology, 2008, 3
  • [30] Durable response after discontinuation of pembrolizumab therapy for intrahepatic cholangiocarcinoma: a case report
    Eguchi, Shimpei
    Shinkawa, Hiroji
    Sato, Yasunori
    Nakai, Kozo
    Takemura, Shigekazu
    Tanaka, Shogo
    Amano, Ryosuke
    Kimura, Kenjiro
    Ohira, Go
    Nishio, Kohei
    Kinoshita, Masahiko
    Tauchi, Jun
    Miyazaki, Toru
    Ishihara, Atsushi
    Shirai, Daisuke
    Kubo, Shoji
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (03) : 858 - 865
12345